Status:
COMPLETED
Prevalence of Hypoglycaemia in Congenital Adrenal Insufficiency
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
URC-CIC Paris Descartes Necker Cochin
Conditions:
Adrenal Insufficiency, Congenital
Eligibility:
All Genders
6-6 years
Phase:
NA
Brief Summary
Children with congenital primary and secondary adrenal insufficiency, who are deficient in cortisol, are at risk for hypoglycaemia, irrespective of appropriate hydrocortisone treatment, which can lead...
Detailed Description
Children with congenital primary and secondary adrenal insufficiency, who are deficient in cortisol, are at risk for hypoglycaemia, irrespective of appropriate hydrocortisone treatment, which can lead...
Eligibility Criteria
Inclusion
- All male and female patients, followed in the Paediatric Endocrinology Department at Necker Hospital, with congenital primary and secondary adrenal insufficiency.
- Age between 6 months and 6 years.
- Included in the social security system.
- Parental consent and willingness to participate in this study: involves training and skills in the use of blood glucometers.
Exclusion
- Patients with acquired adrenal insufficiency.
- Patients with type 1 or type 2 diabetes.
- Patients with somatotropic deficiency associated with adrenal insufficiency.
- Refusal or impossibility to perform the glycaemic measurements according to the procedure of the study.
- Not covered by the social security system.
Key Trial Info
Start Date :
July 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT04322435
Start Date
July 15 2020
End Date
August 31 2022
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Necker-Enfants Malades
Paris, France, 75015